Erythrocin
[ih-rith-ruh-sin] /ɪˈrɪθ rə sɪn/
Pharmacology, Trademark.
1.
a brand of .
Read Also:
- Erythroblastotic
[ih-rith-roh-bla-stoh-sis] /ɪˌrɪθ roʊ blæˈstoʊ sɪs/ noun, Pathology. 1. the presence of in the blood. 2. Also called erythroblastosis fetalis [fi-tal-is] /fɪˈtæl ɪs/ (Show IPA), erythroblastosis neonatorum [nee-uh-nuh-tawr-uh m, -tohr-] /ˌni ə nəˈtɔr əm, -ˈtoʊr-/ (Show IPA). this condition in the fetus or newborn, usually caused by an Rh incompatibility between mother and baby. /ɪˌrɪθrəʊblæˈstəʊsɪs/ noun […]
- Erythroclasis
erythroclasis er·y·throc·la·sis (ěr’ə-thrŏk’lə-sĭs) n. The fragmentation or breaking down of red blood cells.
- Erythroclastic
erythroclastic e·ryth·ro·clas·tic (ĭ-rĭth’rō-klās’tĭk) adj. Destructive to red blood cells.
- Erythrocyanosis
erythrocyanosis e·ryth·ro·cy·a·no·sis (ĭ-rĭth’rō-sī’ə-nō’sĭs) n. A condition caused by exposure to cold and characterized by swelling of the limbs and the appearance of irregular red-blue patches on the skin, occurring especially in girls and women.
- Erythrocyte fragility test
erythrocyte fragility test n. See fragility test.